Published in Cytokine on May 18, 2016
Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol (1998) 3.78
Stability studies of twenty-four analytes in human plasma and serum. Clin Chem (2002) 2.46
Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol (1999) 2.46
Variables that affect assays for plasma cytokines and soluble activation markers. Clin Diagn Lab Immunol (1999) 2.15
Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods (1992) 1.84
Levels of cytokines and immune activation markers in plasma in human immunodeficiency virus infection: quality control procedures. Clin Diagn Lab Immunol (1998) 1.65
Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine (1998) 1.63
Counter-stress effects of relaxation on proinflammatory and anti-inflammatory cytokines. Brain Behav Immun (2008) 1.49
Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods (2008) 1.47
Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine (2000) 1.46
Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care (2010) 1.36
Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods (1992) 1.34
Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha. J Exp Med (1992) 1.28
Stability of interleukin 6, soluble interleukin 6 receptor, interleukin 10 and CC16 in human serum. Cytokine (2002) 1.27
Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring) (2006) 1.25
Cytokines, plasma immune activation markers, and clinically relevant surrogate markers in human immunodeficiency virus infection. Clin Diagn Lab Immunol (1998) 1.25
Measuring circulating cytokines. J Appl Physiol (1985) (1993) 1.25
Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm (2014) 1.16
Studies of the stability of 18 chemical constituents of human serum. Clin Chem (1972) 1.04
Artifacts and limitations of enzyme immunoassay. J Immunol Methods (1992) 1.02
Detection and measurement of cytokines. Blood Rev (1992) 1.02
Effect of serum-clot contact time on clinical chemistry laboratory results. Clin Chem (1998) 1.00
Effects of blood sample age at time of separation on measured cytokine concentrations in human plasma. Clin Vaccine Immunol (2010) 0.99
Effects of serum and plasma matrices on multiplex immunoassays. Immunol Res (2014) 0.95
The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor. Cytokine (1997) 0.94
Cytokines and cytokine measurements in a clinical laboratory. Clin Diagn Lab Immunol (1994) 0.93
Homologous ELISA for detection of oligomeric human TNF: properties of the assay. J Immunol Methods (1995) 0.91
Identification of clinical biomarkers for pre-analytical quality control of blood samples. Biopreserv Biobank (2013) 0.86
Cytokines--protein structure and biological activity: a complex relationship with implications for biological assays and standardization. Biologicals (1993) 0.84
Changes in serum chemical values as a result of prolonged contact with the clot. Am J Clin Pathol (1976) 0.84
Spurious tumor necrosis factor-alpha and interleukin-6 production by human monocytes from blood collected in endotoxin-contaminated vacutainer blood collection tubes. Clin Chem (2004) 0.79